Automated Insulin Delivery Just Got FDA Clearance for Type 2 Diabetes. What Changes for the Pump Market
DDDr. Dereck Mush, MD, MBA
May 26
What they do
The company manufactures the Omnipod system, a wearable, tubeless insulin pump that delivers continuous insulin. Endocrinology clinics and retail pharmacies distribute this device directly to patients with type 1 diabetes seeking an alternative to daily injections.
The record
- Vertical
- Medical Devices
- Sub-segment
- Drug delivery systems
- Product type
- Device
- Stage
- Public
- Headquarters
- Acton, USA
- Region
- North America
- Founded
- 2000
- Total funding
- $160M raised
Notable investors: Prism Venture Partners, Prospect Venture Partners.
Also in Medical Devices
Related on The Signal
The senolytic drug pipeline is narrowing toward a smaller set of credible candidates
DDDr. Dereck Mush, MD, MBA
Apr 14The HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
DDDr. Dereck Mush, MD, MBA
Jul 16
Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
DDDr. Dereck Mush, MD, MBA
Jun 5